PE31195A1 - Derivado de carbazol sustituido, proceso para su preparacion y composicion farmaceutica que lo contiene - Google Patents
Derivado de carbazol sustituido, proceso para su preparacion y composicion farmaceutica que lo contieneInfo
- Publication number
- PE31195A1 PE31195A1 PE1994255110A PE25511094A PE31195A1 PE 31195 A1 PE31195 A1 PE 31195A1 PE 1994255110 A PE1994255110 A PE 1994255110A PE 25511094 A PE25511094 A PE 25511094A PE 31195 A1 PE31195 A1 PE 31195A1
- Authority
- PE
- Peru
- Prior art keywords
- preparation
- pharmaceutical composition
- piridin
- ilo
- alkyl
- Prior art date
Links
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical class C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- KJDGFQJCHFJTRH-YONAWACDSA-N 16-Ketoestradiol Chemical class OC1=CC=C2[C@H]3CC[C@](C)([C@H](C(=O)C4)O)[C@@H]4[C@@H]3CCC2=C1 KJDGFQJCHFJTRH-YONAWACDSA-N 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- WZKSXHQDXQKIQJ-UHFFFAOYSA-N F[C](F)F Chemical class F[C](F)F WZKSXHQDXQKIQJ-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 229930194542 Keto Natural products 0.000 abstract 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- 206010060862 Prostate cancer Diseases 0.000 abstract 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 abstract 1
- 150000001299 aldehydes Chemical class 0.000 abstract 1
- 229940094957 androgens and estrogen Drugs 0.000 abstract 1
- 208000030270 breast disease Diseases 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- ZFTFAPZRGNKQPU-UHFFFAOYSA-N dicarbonic acid Chemical compound OC(=O)OC(O)=O ZFTFAPZRGNKQPU-UHFFFAOYSA-N 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 150000002825 nitriles Chemical class 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 210000001672 ovary Anatomy 0.000 abstract 1
- 210000000496 pancreas Anatomy 0.000 abstract 1
- 210000002307 prostate Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939310635A GB9310635D0 (en) | 1993-05-21 | 1993-05-21 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE31195A1 true PE31195A1 (es) | 1995-10-18 |
Family
ID=10736007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1994255110A PE31195A1 (es) | 1993-05-21 | 1994-11-18 | Derivado de carbazol sustituido, proceso para su preparacion y composicion farmaceutica que lo contiene |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0699196A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JPH08510455A (cg-RX-API-DMAC10.html) |
| CN (1) | CN1126473A (cg-RX-API-DMAC10.html) |
| AU (1) | AU6928794A (cg-RX-API-DMAC10.html) |
| BG (1) | BG100154A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2162921A1 (cg-RX-API-DMAC10.html) |
| CZ (1) | CZ305195A3 (cg-RX-API-DMAC10.html) |
| FI (1) | FI955587A7 (cg-RX-API-DMAC10.html) |
| GB (1) | GB9310635D0 (cg-RX-API-DMAC10.html) |
| HU (1) | HUT73790A (cg-RX-API-DMAC10.html) |
| IL (1) | IL109703A0 (cg-RX-API-DMAC10.html) |
| NO (1) | NO954681D0 (cg-RX-API-DMAC10.html) |
| OA (1) | OA10195A (cg-RX-API-DMAC10.html) |
| PE (1) | PE31195A1 (cg-RX-API-DMAC10.html) |
| PL (1) | PL311702A1 (cg-RX-API-DMAC10.html) |
| SK (1) | SK142495A3 (cg-RX-API-DMAC10.html) |
| TW (1) | TW279866B (cg-RX-API-DMAC10.html) |
| WO (1) | WO1994027989A1 (cg-RX-API-DMAC10.html) |
| ZA (1) | ZA943494B (cg-RX-API-DMAC10.html) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR960704852A (ko) * | 1993-09-30 | 1996-10-09 | 오노다 마사요시 | 아졸 유도체 및 이의 약제학적 조성물 (Azole derivative and pharmaceutical composition thereof) |
| WO1996014090A1 (en) * | 1994-11-07 | 1996-05-17 | Janssen Pharmaceutica N.V. | Compositions comprising carbazoles and cyclodextrins |
| AU702406B2 (en) * | 1995-03-01 | 1999-02-18 | Yamanouchi Pharmaceutical Co., Ltd. | Imidazole derivatives and medicinal composition thereof |
| CA2281598A1 (en) * | 1997-02-21 | 1998-08-27 | Tetsuya Aono | Fused ring compounds, process for producing the same and use thereof |
| MXPA03004347A (es) | 2000-11-17 | 2004-05-04 | Takeda Chemical Industries Ltd | Nuevos derivados de imidazol, metodo de produccion y uso de los mismos. |
| US6960586B2 (en) | 2000-11-20 | 2005-11-01 | Takeda Pharmaceutical Company Limited | Imidazole derivatives, process for their preparation and their use |
| EP1348706B1 (en) | 2000-12-08 | 2009-08-19 | Takeda Pharmaceutical Company Limited | Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof |
| DK1902026T3 (da) | 2005-06-24 | 2010-04-26 | Lilly Co Eli | Tetrahydrocarbazol-derivater, der kan anvendes som androgen-receptor-modulatorer (SARM) |
| US8093279B2 (en) | 2005-12-13 | 2012-01-10 | Gillian Reed, legal representative | Compound |
| GB0525323D0 (en) * | 2005-12-13 | 2006-01-18 | Sterix Ltd | Compound |
| CN100586932C (zh) * | 2007-01-26 | 2010-02-03 | 中国医学科学院医药生物技术研究所 | 抗肿瘤化合物及其制备方法 |
| KR101360725B1 (ko) | 2009-06-26 | 2014-02-07 | 노파르티스 아게 | Ｃｙｐ17의 억제제로서의 1,3-이치환된 이미다졸리딘-2-온 유도체 |
| AU2011212813B2 (en) | 2010-02-04 | 2014-10-23 | Radius Health, Inc. | Selective androgen receptor modulators |
| CA2799183A1 (en) | 2010-05-12 | 2011-11-17 | Radius Health, Inc. | Therapeutic regimens |
| US9132105B2 (en) | 2010-08-04 | 2015-09-15 | Pellficure Pharmaceuticals, Inc. | Treatment of prostate carcinoma |
| US8946260B2 (en) | 2010-09-16 | 2015-02-03 | Novartis Ag | 17α-hydroxylase/C17,20-lyase inhibitors |
| US9133182B2 (en) | 2010-09-28 | 2015-09-15 | Radius Health, Inc. | Selective androgen receptor modulators |
| WO2012149413A1 (en) | 2011-04-28 | 2012-11-01 | Novartis Ag | 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS |
| US9492460B2 (en) * | 2013-02-27 | 2016-11-15 | Bristol-Myers Squibb Company | Carbazole compounds useful as bromodomain inhibitors |
| US20160022606A1 (en) | 2013-03-14 | 2016-01-28 | Pellficure Pharmaceuticals Inc. | Novel therapy for prostate carcinoma |
| US9421264B2 (en) | 2014-03-28 | 2016-08-23 | Duke University | Method of treating cancer using selective estrogen receptor modulators |
| HRP20251500T1 (hr) | 2014-03-28 | 2026-01-02 | Duke University | Liječenje raka dojke pozitivnog na receptor estrogena uporabom selektivnih modulatora receptora estrogena |
| US10093620B2 (en) | 2014-09-12 | 2018-10-09 | Pellficure Pharmaceuticals, Inc. | Compositions and methods for treatment of prostate carcinoma |
| ES2913470T3 (es) | 2016-06-22 | 2022-06-02 | Ellipses Pharma Ltd | Métodos de tratamiento de cáncer de mama AR+ |
| CA3044812A1 (en) | 2016-10-24 | 2018-05-03 | Pellficure Pharmaceuticals Inc. | Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1,4-dione |
| AU2018205285C9 (en) | 2017-01-05 | 2024-05-23 | Radius Pharmaceuticals, Inc. | Polymorphic forms of RAD1901-2HCl |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS229934B2 (en) * | 1981-07-07 | 1984-07-16 | Pfizer | Production method subst.indolylacryte acid derivative |
| GB8518743D0 (en) * | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Heterocyclic compounds |
-
1993
- 1993-05-21 GB GB939310635A patent/GB9310635D0/en active Pending
-
1994
- 1994-05-02 ZA ZA943494A patent/ZA943494B/xx unknown
- 1994-05-17 TW TW083104441A patent/TW279866B/zh active
- 1994-05-19 HU HU9503321A patent/HUT73790A/hu unknown
- 1994-05-19 EP EP94917647A patent/EP0699196A1/en not_active Withdrawn
- 1994-05-19 CN CN94192683A patent/CN1126473A/zh active Pending
- 1994-05-19 JP JP7500181A patent/JPH08510455A/ja active Pending
- 1994-05-19 SK SK1424-95A patent/SK142495A3/sk unknown
- 1994-05-19 CZ CZ953051A patent/CZ305195A3/cs unknown
- 1994-05-19 WO PCT/EP1994/001613 patent/WO1994027989A1/en not_active Ceased
- 1994-05-19 CA CA002162921A patent/CA2162921A1/en not_active Abandoned
- 1994-05-19 PL PL94311702A patent/PL311702A1/xx unknown
- 1994-05-19 AU AU69287/94A patent/AU6928794A/en not_active Abandoned
- 1994-05-20 IL IL10970394A patent/IL109703A0/xx unknown
- 1994-11-18 PE PE1994255110A patent/PE31195A1/es not_active Application Discontinuation
-
1995
- 1995-11-17 OA OA60742A patent/OA10195A/en unknown
- 1995-11-20 FI FI955587A patent/FI955587A7/fi not_active Application Discontinuation
- 1995-11-20 NO NO954681A patent/NO954681D0/no unknown
- 1995-11-21 BG BG100154A patent/BG100154A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL311702A1 (en) | 1996-03-04 |
| FI955587A0 (fi) | 1995-11-20 |
| TW279866B (cg-RX-API-DMAC10.html) | 1996-07-01 |
| CA2162921A1 (en) | 1994-12-08 |
| AU6928794A (en) | 1994-12-20 |
| ZA943494B (en) | 1995-01-23 |
| SK142495A3 (en) | 1996-06-05 |
| NO954681L (no) | 1995-11-20 |
| WO1994027989A1 (en) | 1994-12-08 |
| CZ305195A3 (en) | 1996-06-12 |
| IL109703A0 (en) | 1994-08-26 |
| HUT73790A (en) | 1996-09-30 |
| OA10195A (en) | 1996-12-18 |
| GB9310635D0 (en) | 1993-07-07 |
| JPH08510455A (ja) | 1996-11-05 |
| NO954681D0 (no) | 1995-11-20 |
| HU9503321D0 (en) | 1996-01-29 |
| FI955587A7 (fi) | 1995-11-20 |
| CN1126473A (zh) | 1996-07-10 |
| EP0699196A1 (en) | 1996-03-06 |
| BG100154A (en) | 1996-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE31195A1 (es) | Derivado de carbazol sustituido, proceso para su preparacion y composicion farmaceutica que lo contiene | |
| PE20060162A1 (es) | Sintesis de compuestos de ester y acido borico | |
| Hubert et al. | A Novel Reductive Cyclization of Imides | |
| MY123467A (en) | Preparation of sterically hindered amine ethers | |
| KR850004462A (ko) | 1,3,4,5-테트라히드로벤즈[c,d]인돌류 제조방법 | |
| PE13391A1 (es) | Procedimiento de preparacion de derivados de piperazina | |
| Elion et al. | The direct thiation of uracils | |
| KR890014470A (ko) | 카르바펜엠 중간체의 제조방법 | |
| ES8506594A1 (es) | Un procedimiento para obtener derivados de indanilbenzamida | |
| Taguchi et al. | Regio-and stereoselective synthesis of gem-difluorocyclopropanes using 4-bromo-4, 4-difluorocrotonate | |
| PE20011078A1 (es) | PROCEDIMIENTO DE OBTENCION DE LOS DERIVADOS DE DIBENZO [b, f] AZEPINA | |
| AR246523A1 (es) | Procedimiento para preparar acidos 1,3,4,9-tetra-hidropirano¡3,4-b¿indol-1-aceticos sustituidos. | |
| KR920002525A (ko) | 4-시아노-3-플루오로페닐에스테르 | |
| NO159079C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive alkan- og alken-derivater. | |
| Graziano et al. | Oxidation of fully substituted alkoxyoxazolcs with singlet molecular oxygen | |
| CN114349656B (zh) | 一种酰肼类化合物的制备方法 | |
| Corey et al. | Synthetic imino analogs of Cecropia juvenile hormones as potentiators of juvenile hormone activity | |
| US3968112A (en) | Synthesis of penniclavine and elymoclavine | |
| US2606914A (en) | delta8(9)14-androstadienes and method of preparing the same | |
| ES2032809T3 (es) | Metodo para producir un compuesto de 7-bromo-b-carbolina. | |
| ES8506257A1 (es) | Un procedimiento de preparar un nuevo ester de un acido acetico sustituido | |
| GB1128046A (en) | Benzofuran derivatives and compositions containing same | |
| ES2034537T3 (es) | Procedimiento para la obtencion de derivados del acido 5-(n-3,4,5,6-tetrahidroftalimido)-canimico. | |
| GB1115886A (en) | Plant morphology regulating compositions and substituted fluorenes for use therein | |
| FR2398064A1 (fr) | Nouveau procede de preparation de la 5,6-diamino-uracile a partir de la 5-nitroso-6-amino-uracile |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |